Researchers have found that the widely prescribed asthma drug Singulair may be linked to serious mental health problems for some patients, Reuters reports.

New York Post

New York

United States

Ad Fontes Media

All Sides

Media Bias/Fact Check

Murdoch family

Researchers at the US Food and Drug Administration (FDA) have made new findings about a widely prescribed asthma drug. According to studies, the product known under the brand name Singulair and montelukast can cause serious mental problems in some patients. The results were presented in a scientific presentation - reported <a href="https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-finds-widely-used-asthma-drug-impacts-brain- 202…

Az Egyesült Államok Élelmiszer- és Gyógyszerügyi Hivatala (FDA) kutatói új megállapításokat tettek egy széles körben felírt asztma elleni gyógyszerrel kapcsolatban. A vizsgálatok szerint a Singulair márkanéven, illetve montelukaszt néven ismert készítmény egyes betegeknél súlyos mentális problémákat okozhat. Az eredmények egy tudományos előadás keretében ismertették - számolt be a <a href="https://www.reuters.com/business/healthcare-pharmaceutic…

Figyelem, súlyos mentális zavarokat okozhat az ismert asztmagyógyszer: öngyilkosságokat is kötnek már hozzá - Pénzcentrum

Pénzcentrum

Attention, the well-known asthma medicine can cause serious mental disorders: suicides are already linked to it - Pénzcentrum

When Merck debuted its Singulair asthma pill in the late '90s, an appealing alternative to asthma sufferers who relied on inhalers, the pharmaceuticals company compared it to a "sugar pill" in terms of side effects, calling any distribution of the drug to the brains of the millions of adults and...

Newser

Patrick Spain, Michael Wolff

Miami

Miami-Dade County

Florida

FDA: Asthma Drug Tied to Mental Health Issues

(November 23, 2024, Venezuelan).- Researchers from the U.S. government have found that a widely prescribed drug for asthma could be related to serious mental health problems, including the development of suicidal thoughts. As reported on Friday Reuters, which echoes a scientific presentation on the drug originally sold by Merck & Co under the Singulair brand name and generically as montelukast. Launched in 1998, Singulair offered pill-like relie…

(23 de noviembre del 2024. El Venezolano).- Investigadores del Gobierno estadounidense han descubierto que un fármaco ampliamente recetado para el asma podría estar relacionado con graves problemas de salud mental, incluido el desarrollo de pensamientos suicidas. Así lo informó el viernes Reuters, que se hace eco de una presentación científica sobre el medicamento vendido originalmente por Merck & Co bajo la marca Singulair y genéricamente como …

Vinculan un popular medicamento para el asma con conductas suicidas – El Venezolano News

El Venezolano News

They link a popular asthma medicine with suicidal behaviors – El Venezolano News

Researchers from the U.S. government have found that a widely prescribed drug for asthma could be related to serious mental health problems, including the development of suicidal thoughts. As reported on Friday Reuters, which echoes a scientific presentation on the drug originally sold by Merck & Co under the Singulair brand name and generically as montelukast. Launched in 1998, Singulair offered pill-shaped relief as an alternative to inhaler. …

Investigadores del Gobierno estadounidense han descubierto que un fármaco ampliamente recetado para el asma podría estar relacionado con graves problemas de salud mental, incluido el desarrollo de pensamientos suicidas. Así lo informó el viernes Reuters, que se hace eco de una presentación científica sobre el medicamento vendido originalmente por Merck & Co bajo la marca Singulair y genéricamente como montelukast. 
Lanzado en 1998, Singulair ofr…

Popular asthma drug may be linked to serious mental health problems

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics